These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32545231)

  • 1. Impact of Nasal Swabs on Empiric Treatment of Respiratory Tract Infections (INSERT-RTI).
    Huffman V; Andrade DC; Ham J; Brown K; Melnitsky L; Lopez Cohen A; Parmar J
    Pharmacy (Basel); 2020 Jun; 8(2):. PubMed ID: 32545231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a Pharmacist-driven Methicillin-resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Protocol on the De-escalation of Empiric Vancomycin in Patients with Pneumonia in a Rural Healthcare Setting.
    Dadzie P; Dietrich T; Ashurst J
    Cureus; 2019 Dec; 11(12):e6378. PubMed ID: 31938656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia.
    Dunaway S; Orwig KW; Arbogast ZQ; Myers ZL; Sizemore JA; Giancola SE
    Int J Clin Pharm; 2018 Jun; 40(3):526-532. PubMed ID: 29721739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of negative methicillin-resistant Staphylococcus aureus (MRSA) nasal surveillance swabs in skin and skin structure infections.
    Burgoon R; Weeda E; Mediwala KN; Raux BR
    Am J Infect Control; 2022 Aug; 50(8):941-946. PubMed ID: 34958856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy in Intensive Care Unit Patients.
    Chotiprasitsakul D; Tamma PD; Gadala A; Cosgrove SE
    Infect Control Hosp Epidemiol; 2018 Mar; 39(3):290-296. PubMed ID: 29374504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of Gram-negative antibiotic therapy in patients with pneumonia prior to and after the implementation of MRSA nasal swabs, an antimicrobial stewardship tool.
    Troyer BS; Shigle AJ; Kovacic Scherrer N
    J Antimicrob Chemother; 2022 Aug; 77(9):2557-2560. PubMed ID: 35733340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit.
    Diep C; Meng L; Pourali S; Hitchcock MM; Alegria W; Swayngim R; Ran R; Banaei N; Deresinski S; Holubar M
    Am J Health Syst Pharm; 2021 Dec; 78(24):2236-2244. PubMed ID: 34297040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia.
    Baby N; Faust AC; Smith T; Sheperd LA; Knoll L; Goodman EL
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a pharmacist-driven methicillin-resistant
    Willis C; Allen B; Tucker C; Rottman K; Epps K
    Am J Health Syst Pharm; 2017 Nov; 74(21):1765-1773. PubMed ID: 29070498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRSA nasal swab PCR to de-escalate antibiotics in the emergency department.
    Sindelar MA; Zepeski AE; Lawler BJ; Johnston SD; Faine BA
    Am J Emerg Med; 2022 May; 55():133-137. PubMed ID: 35313228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swab Testing to Optimize Pneumonia treatment with empiric Vancomycin (STOP-Vanc): study protocol for a randomized controlled trial.
    Freiberg JA; Siemann JK; Qian ET; Ereshefsky BJ; Hennessy C; Stollings JL; Rali TM; Harrell FE; Gatto CL; Rice TW; Nelson GE;
    Res Sq; 2024 Jun; ():. PubMed ID: 38947088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment.
    Sarikonda KV; Micek ST; Doherty JA; Reichley RM; Warren D; Kollef MH
    Crit Care Med; 2010 Oct; 38(10):1991-5. PubMed ID: 20683260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of MRSA Nasal Swabs as an Antimicrobial Stewardship Intervention to Decrease Anti-MRSA Therapy in COVID-19 Infection.
    DeKerlegand A; Johnston E; Mellor B; Schrack MR; O'Neal C
    Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review of the Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening for MRSA Pneumonia.
    Smith MN; Brotherton AL; Lusardi K; Tan CA; Hammond DA
    Ann Pharmacother; 2019 Jun; 53(6):627-638. PubMed ID: 30600697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Utility of Methicillin-Resistant Staphylococcus aureus Nasal Screening for Antimicrobial Stewardship: A Review of Current Literature.
    Carr AL; Daley MJ; Givens Merkel K; Rose DT
    Pharmacotherapy; 2018 Dec; 38(12):1216-1228. PubMed ID: 30300441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Daniel K. Inouye College of Pharmacy Scripts: The Effects of Vancomycin Use and De-escalation in Patients Hospitalized with Pneumonia.
    You AS; Fukunaga BT; Hanlon AL; Lozano AJ; Goo RA
    Hawaii J Med Public Health; 2018 Oct; 77(10):261-267. PubMed ID: 30324005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal-Swab Results for Methicillin-Resistant
    Rioux J; Edwards J; Bresee L; Abu-Ulba A; Yu S; Dersch-Mills D; Wilson B
    Can J Hosp Pharm; 2017; 70(2):107-112. PubMed ID: 28487577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of nares swab to de-escalate vancomycin for patients with suspected methicillin-resistant
    Gentges J; El-Kouri N; Rahman T; Mushtaq N; Hudson E; Scheck D
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e167. PubMed ID: 38028911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Anti-Methicillin-Resistant
    Pelham M; Ganter M; Eudy J; Anderson DT
    Pharmacy (Basel); 2023 May; 11(3):. PubMed ID: 37218963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a Pharmacist-Driven MRSA Nasal PCR Protocol on Pneumonia Therapy.
    Pham SN; Sturm AC; Jacoby JS; Egwuatu NE; Dumkow LE
    Hosp Pharm; 2021 Aug; 56(4):221-227. PubMed ID: 34381253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.